Conventional and Genetic Evidence on the Association between Adiposity and CKD.
Journal article
Zhu P. et al, (2020), J Am Soc Nephrol
International consensus definitions of clinical trial outcomes for kidney failure: 2020
Journal article
Levin A. et al, (2020), Kidney International, 98, 849 - 859
Pre-randomization run-in periods in randomized controlled trials of chronic diseases: a methodological study.
Journal article
Collister D. et al, (2020), J Clin Epidemiol
CONVENTIONAL AND GENETIC EVIDENCE ON THE ASSOCIATION BETWEEN ADIPOSITY AND CHRONIC KIDNEY DISEASE
Journal article
HERRINGTON W. et al, (2020), Journal of the American Society of Nephrology
Association of Blood Pressure With Cause-Specific Mortality in Mexican Adults.
Journal article
Tapia-Conyer R. et al, (2020), JAMA Netw Open, 3
Blood pressure and kidney disease: chicken or egg (or both)?
Journal article
Staplin N. et al, (2020), Kidney Int, 98, 547 - 549
In patients with coronary disease and CKD, adding an invasive strategy to MT did not improve outcomes.
Journal article
Herrington WG. and Staplin N., (2020), Ann Intern Med, 173
In patients with coronary disease and CKD, initial invasive therapy did not improve angina-related health status.
Journal article
Herrington WG. and Staplin N., (2020), Ann Intern Med, 173
Erratum: The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study.
Journal article
Herrington WG. et al, (2020), Clin Kidney J, 13
Cross-sectional associations between central and general adiposity with albuminuria: observations from 400,000 people in UK Biobank.
Journal article
Zhu P. et al, (2020), Int J Obes (Lond)
Establishing Core Cardiovascular Outcome Measures for Trials in Hemodialysis: Report of an International Consensus Workshop
Conference paper
O'Lone E. et al, (2020), American Journal of Kidney Diseases, 76, 109 - 120
Haemodialysis, blood pressure and risk: at the limit of non-randomized evidence.
Other
Ng SYA. et al, (2020), Nephrol Dial Transplant
In type 2 diabetes, SGLT-2 inhibitors reduce risk for major kidney outcomes.
Journal article
Ai Ng SY. et al, (2020), Ann Intern Med, 172
Accelerometer-measured physical activity and functional behaviours among people on dialysis
Journal article
Nawab K. et al, (2020), Clinical Kidney Journal
Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals.
Journal article
O'Lone E. et al, (2020), Nephrol Dial Transplant
Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Journal article
Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol
Kidney disease trials for the 21st century: innovations in design and conduct.
Journal article
Herrington WG. et al, (2019), Nat Rev Nephrol
Body composition and mortality from vascular or metabolic causes among 150,000 participants in the Mexico City Prospective Study
Conference paper
Gnatiuc L. et al, (2019), EUROPEAN HEART JOURNAL, 40, 2412 - 2412
General and Abdominal Adiposity and Mortality in Mexico City: A Prospective Study of 150 000 Adults.
Journal article
Gnatiuc L. et al, (2019), Ann Intern Med, 171, 397 - 405
Cost-effectiveness of lipid lowering with statins and ezetimibe in chronic kidney disease.
Journal article
Schlackow I. et al, (2019), Kidney Int, 96, 170 - 179